109
0
0
Like?
Please wait...
About This Project
We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.
Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.
Recent Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
Managing Congenital Adrenal Hyperplasia in the Amish Population
Congenital adrenal hyperplasia (CAH) is a disorder that affects the production of hormones critical for...
Can we Measure the Body's Response to Implants by Testing the Blood?
Would you or a loved one someday benefit from a life-saving medical implant? However, the organisms adapt...
A Leap Forward to Cure a Neglected Disease
The World Health Organization estimates that as many as 11 million people worldwide are infected with the...